Analytical quality by design in the development of a solvent-modified micellar electrokinetic chromatography method for the determination of sitagliptin and its related compounds.
Capillary electrophoresis
Experimental design
Impurities
Method operable design region
Quality by design
Sitagliptin
Journal
Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336
Informations de publication
Date de publication:
05 Aug 2021
05 Aug 2021
Historique:
received:
12
04
2021
revised:
19
05
2021
accepted:
20
05
2021
pubmed:
31
5
2021
medline:
22
6
2021
entrez:
30
5
2021
Statut:
ppublish
Résumé
A solvent-modified micellar electrokinetic chromatography method was developed following the Quality by Design approach for the simultaneous determination of sitagliptin (SIT), an oral antihyperglycemic drug, and its main impurities derived from the synthesis process. The separation system was identified in the scouting phase and was made by sodium dodecyl sulphate (SDS) micelles with the addition of n-butanol and methanol. The knowledge space was investigated through an asymmetric screening matrix, taking into consideration eight critical method parameters (CMPs) involving the composition of the background electrolyte in terms of buffer concentration and pH, the concentration of surfactants and organic modifiers, and voltage. The critical method attributes (CMAs) were identified as analysis time and the distance between the tail of the electroosmotic flow system peak and the front edge of impurity I
Identifiants
pubmed: 34052552
pii: S0731-7085(21)00274-0
doi: 10.1016/j.jpba.2021.114163
pii:
doi:
Substances chimiques
Micelles
0
Solvents
0
Sodium Dodecyl Sulfate
368GB5141J
Sitagliptin Phosphate
TS63EW8X6F
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114163Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors report no declarations of interest.